CanSino Biologics Inc. logo

CanSino Biologics Inc.

HKEX:6185.HK

Overview | Financials
Company Name CanSino Biologics Inc.
Symbol 6185.HK
Currency HKD
Price 18.58
Market Cap 6,294,898,147
Dividend Yield 0%
52-week-range 14.8 - 29.15
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Xuefeng Yu Ph.D.
Website https://www.cansinotech.com

An error occurred while fetching data.

About CanSino Biologics Inc.

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine

Related Stocks

China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited

3320.HK

5.22 HKD

Livzon Pharmaceutical Group Inc. logo

Livzon Pharmaceutical Group Inc.

1513.HK

21.7 HKD

Innovent Biologics, Inc. logo

Innovent Biologics, Inc.

1801.HK

43.15 HKD

China Medical System Holdings Limited logo

China Medical System Holdings Limited

0867.HK

7.12 HKD

Zai Lab Limited logo

Zai Lab Limited

9688.HK

15.68 HKD

Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited

2096.HK

6.1 HKD

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. logo

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

9989.HK

3.82 HKD

MicroPort Scientific Corporation logo

MicroPort Scientific Corporation

0853.HK

4.66 HKD

China Evergrande New Energy Vehicle Group Limited logo

China Evergrande New Energy Vehicle Group Limited

0708.HK

0.246 HKD

Hygeia Healthcare Holdings Co., Limited logo

Hygeia Healthcare Holdings Co., Limited

6078.HK

16 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD